Strobeck Matthew
- SEC CIK
- 0001377832
In the past year, 1 open-market purchase filing worth $239.6K and no sales.
Current role at each company
- QDEL QuidelOrtho CorpDirectoras of Jun 2, 2026
- BDSX Biodesix IncDirectoras of Jan 6, 2026
- ELUT Elutia Inc.Other: 10% owner in previous filingas of Feb 20, 2024
- AXDX Accelerate Diagnostics, IncDirectoras of Jan 25, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $239.6K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$239.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Strobeck Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QDEL QuidelOrtho Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 (view filing) | Feb 13 | Same day | Strobeck MatthewDirector | PPurchase | +10.0K | $23.96 | +$239.6K | +56.3%27.8K after |
BDSX Biodesix Inc
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 (view filing) | Nov 5 | 1 day | Strobeck MatthewDirector | PPurchase | +40.0K | $1.40 | +$56.0K | +1.6%2.61M after | 2 lots |
| Nov 21, 2022 (view filing) | Nov 21 | Same day | Strobeck MatthewDirector | PPurchase | +869.6K | $1.15 | +$1.00M | +56.3%2.42M after | |
| Nov 21, 2022 (view filing) | Nov 21 | Same day | Strobeck MatthewDirector | PPurchase | +1.80M | $1.15 | +$2.07M | +537.2%2.14M after | 5 lots |
| Apr 11, 2022 (view filing) | Apr 7 | 4 days | Strobeck MatthewDirector | PPurchase | +558.7K | $1.79 | +$1.00M | +56.6%1.55M after | |
| Apr 11, 2022 (view filing) | Apr 7 | 4 days | Strobeck MatthewDirector | PPurchase | +558.7K | $1.79 | +$1.00M | +264.5%769.9K after | |
| Jan 4, 2022 (view filing) | Dec 30, 2021 | 5 days | Strobeck MatthewDirector | PPurchase | +147.8K | $4.35 | +$642.9K | New position19.9K after | 2 lots |
ELUT Elutia Inc.
Other: 10% owner in previous filing2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 (view filing)12:27 PM ET | Mar 23-27, 2023 | 334 days | Strobeck Matthew and 2 othersOther: 10% owner in previous filing | PPurchaseClass A Common Stock | +140.0K | $1.48 | +$207.0K | +9.2%1.66M after | Amended5 lots |
| Feb 13, 2023 (view filing)7:01 PM ET | May 11-Dec 8, 2022 | 278 daysLate | Strobeck Matthew and 2 others10% Owner | PPurchaseClass A Common Stock | +97.3K | $4.09 | +$398.2K | +6.9%1.52M after | 6 lots |
AXDX Accelerate Diagnostics, Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 (view filing) | Jan 23 | 2 days | Strobeck MatthewDirector | PPurchase | +100.0K | – | – | +483.5%120.7K after | |
| Jan 25, 2024 (view filing) | Jan 23 | 2 days | Strobeck MatthewDirector | PPurchase | +100.0K | – | – | –100.0K after | Derivative |